Drug Development

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Articles

FDA urges manufacturers to seek fast approval of “high-need” generics and targeted therapies. 

Gottlieb Tackles Opioids,  Drug Costs, and Innovation

Watson-Marlow Fluid Technology Group (WMFTG) has expanded its range of peristaltic cased pumps for upstream and downstream bioprocessing tasks. 

Larger Peristaltic Pumps Allow Scale-Up

Sartorius Stedim Biotech has expanded its range of single-use membrane chromatography solutions with Sartobind Cassettes, a pod-like modular system for commercial applications in both capture and polishing.

Single-Use Systems Expand Scale of Chromatography

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Safe and effective drug targeting with ADCs requires careful selection of drug, antibody, and linker.

Targeting Drug Delivery with ADCs

Managing and prioritizing risk is essential to ensuring raw material quality. USP is developing new guidelines to make the work easier. 

The Role of Quality Standards for Biomanufacturing Raw Materials

Horizon to make publicly available its complete annotated CHO cell-line sequence in hopes of driving bioproduction cell-line innovation.


Horizon Discovery Releases CHO Genome Sequence for Bioproduction

FDA advances the progress of biosimilars with acceptance of regulatory filing for biosimilar referencing a blockbuster biologic by Roche.

FDA Accepts Application for Teva’s Herceptin Biosimilar

Agnes Shanley is senior editor of Pharmaceutical Technology.

Successful development requires coordinating and aligning drug and device design, focusing on a complete drug delivery system that meets patients’ needs.

Taking a Systems Approach to Inhalation Therapy Development

Partnership aims to develop new vaccine regimens against hep B and HIV by combining respective proprietary vaccine technologies.

Janssen, Bavarian Nordic Partner on Hep B and HIV Vaccines

ipharm set up a manufacturing line at its facility in Sweden using LIDD’s NanoZolid technology.

Formulation and Drug Delivery